Hyseq buys Variagenics
This article was originally published in The Gray Sheet
Executive Summary
Cambridge, Massachusetts pharmacogenomics firm's cancer diagnostics program is a key driver of $55.9 mil. stock purchase. Merged firm will be located at current Hyseq headquarters in Sunnyvale, California. Cash resulting from the deal is expected to fund operations through December 2004...